中国慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的诊断与治疗指南(2025年版)  

The guidelines for diagnosis and treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma in China(2025)

作　　者：中国抗癌协会血液肿瘤专业委员会 中华医学会血液学分会 中国慢性淋巴细胞白血病工作组 李建勇 邱录贵 徐卫 易树华 Hematological Oncology Committee of China Anti-Cancer Association;Hematology Committee of Chinese Medical Association;Chinese Working Group for Chronic Lymphocytic Leukemia;Li Jianyong;Qiu Lugui(不详;Lymphoma Center,Department of Hematology,the First Affiliated Hospital of Nanjing Medical University,Jiangsu Province Hospital,Nanjing 210029,China;State Key Laboratory of Experimental Hematology,National Clinical Research Center for Blood Diseases,Haihe Laboratory of Cell Ecosystem,Institute of Hematology&Blood Diseases Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Tianjin 300020,China)

机构地区：[1]不详 [2]南京医科大学第一附属医院,江苏省人民医院血液科、淋巴瘤中心,南京2210029 [3]中国医学科学院血液病医院(中国医学科学院血液学研究所),血液与健康全国重点实验室,国家血液系统疾病临床医学研究中心,细胞生态海河实验室,天津300020 [4]南京医科大学第一附属医院 [5]中国医学科学院血液病医院(中国医学科学院血液学研究所)

出　　处：《中华血液学杂志》2025年第2期105-112,共8页Chinese Journal of Hematology

基　　金：中国医学科学院医学与健康科技创新工程(CAMS-2022-I2M-1-022)。

摘　　要：慢性淋巴细胞白血病(CLL)/小淋巴细胞淋巴瘤(SLL)是主要发生在中老年人群的、具有特殊免疫表型的成熟B淋巴细胞克隆增殖性肿瘤。近年来,CLL/SLL的基础与临床研究,特别是新药治疗领域取得了巨大进展。为提高我国医务工作者对CLL/SLL的诊断、鉴别诊断及规范化治疗水平,中国抗癌协会血液肿瘤专业委员会、中华医学会血液学分会和中国慢性淋巴细胞白血病工作组对中国CLL/SLL的诊断与治疗指南(2022年版)进行了修订,制订了本版指南。Chronic lymphocytic leukemia(CLL)/Small lymphocytic lymphoma(SLL)is a mature B cell neoplasm with specific immunophenotype,mainly occurs in the middle-aged and elderly population.In recent years,there has been significant progress in the basic and clinical research of CLL/SLL,especially in the field of new drug treatments.To improve the diagnostic,differential diagnostic,and standardized treatment levels of CLL/SLL for medical workers in China,Hematological Oncology Committee of China Anti-Cancer Association,Hematology Committee of Chinese Medical Association,Chinese Working Group for Chronic Lymphocytic Leukemia have revised the guidelines for the diagnosis and treatment of Chinese CLL/SLL(2022 edition)and formulated this version of the guidelines.

关 键 词：SLL 中老年人群 新药治疗 CLL 肿瘤 

分 类 号：R733.1[医药卫生—肿瘤]